Despite advances in lymphoma treatments, improving the prognosis for patients with relapsed and treatment-resistant disease remains a challenge. The early success of several precision therapies associated with fewer side effects than conventional approaches offers new hope for conquering aggressive disease.
http://ift.tt/1s5DJNa
http://ift.tt/1s5DJNa
No comments:
Post a Comment